Difficulty: Medium
Average Score: 83%
Practice
Which one of the following antibiotics is a potent inducer of hepatic drug-metabolizing enzymes?
Correct answer
D
Rationale
In this question, the correct answer is D) Rifampin. Rifampin is a potent inducer of hepatic drug-metabolizing enzymes, particularly cytochrome P450 enzymes. This property of rifampin can lead to increased metabolism and decreased efficacy of co-administered drugs.
Option A) Ciprofloxacin is a fluoroquinolone antibiotic that is not known to be a potent inducer of hepatic drug-metabolizing enzymes.
Option B) Cyclosporine is an immunosuppressant medication that is primarily metabolized by the liver but is not a potent inducer of hepatic drug-metabolizing enzymes like rifampin.
Option C) Erythromycin is a macrolide antibiotic that is not a potent inducer of hepatic drug-metabolizing enzymes, unlike rifampin.
Educationally, understanding the concept of drug interactions and the role of hepatic enzymes in drug metabolism is crucial for healthcare professionals to ensure safe and effective drug therapy for patients. Knowing which drugs are potent enzyme inducers, like rifampin, can help in predicting and managing potential drug interactions and their clinical implications.
Option A) Ciprofloxacin is a fluoroquinolone antibiotic that is not known to be a potent inducer of hepatic drug-metabolizing enzymes.
Option B) Cyclosporine is an immunosuppressant medication that is primarily metabolized by the liver but is not a potent inducer of hepatic drug-metabolizing enzymes like rifampin.
Option C) Erythromycin is a macrolide antibiotic that is not a potent inducer of hepatic drug-metabolizing enzymes, unlike rifampin.
Educationally, understanding the concept of drug interactions and the role of hepatic enzymes in drug metabolism is crucial for healthcare professionals to ensure safe and effective drug therapy for patients. Knowing which drugs are potent enzyme inducers, like rifampin, can help in predicting and managing potential drug interactions and their clinical implications.